Abstract
The aim of this study is to analyze consequences of the poor anticoagulation control with VKA, in terms of thrombotic events, bleedings and mortality, in patients with non-valvular atrial fibrillation (NVAF). The use of healthcare resources and healthcare costs are also estimated.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
